Total revenues in 3Q26 were $39.4 million

3Q26 net loss was $10.0 million and Adjusted EBITDA¹ was $(0.6) million

Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal third quarter ended March 31, 2026. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted.

Presentation of Results

In January 2026, the Company's Pro Farm Group (PFG) business was subject to a foreclosure auction and has been classified as discontinued operations. Accordingly, unless otherwise indicated, the financial results discussed below reflect the Company's continuing operations for all periods presented, and prior-year amounts have been recast to exclude the PFG business.

Financial & Business Highlights

Total revenues were $39.4 million in 3Q26, a 23% year-over-year decline, reflecting softer demand and competitive pressures in Crop Protection, together with the ongoing transition in Seeds. Crop Nutrition revenues increased 15% during the quarter.
Gross profit was $12.7 million, with gross margin of 32%, reflecting lower revenues and product mix effects across segments. Crop Nutrition results were impacted by a non-recurring obsolescence adjustment in inoculants related to inventory normalization efforts.
SG&A expenses declined 16% year over year, reflecting continued execution of organizational streamlining and cost management initiatives across the continuing operations.
Net loss was $10.0 million and Adjusted EBITDA¹ was $(0.6) million, primarily reflecting lower gross profit and the absence of prior-year non-cash income associated with the reorganization in Seeds.
Following the Pro Farm foreclosure auction earlier this year, and the related noteholder dispute, the Company continued advancing liability management initiatives across its operating subsidiaries, including debt reprofiling efforts and a voluntary bond maturity extension process in Argentina.

Management Review

Mr. Federico Trucco, Bioceres' Chief Executive Officer, commented: "This quarter reflects a period of transition and operational refocusing for the Company. While market conditions in several areas of our business remain challenging, and the effects of the transition in Seeds continue to weigh on reported results, we are increasingly focused on strengthening the fundamentals of the organization and prioritizing disciplined execution across the platform.

"During the quarter, we continued advancing initiatives aimed at simplifying the organization, improving operational efficiency, strengthening working capital management and improving cash generation and liability management across key operating subsidiaries. In parallel, we are reinforcing governance and internal processes and conducting a strategic review of our continuing operations — including initiatives focused on organizational streamlining and capital allocation optimization — to ensure that capital, management attention, and resources remain aligned with the areas where we believe we can create the greatest long-term value.

"We recognize the significance of the events surrounding Pro Farm and the uncertainty generated by the ongoing litigation process. While we continue to pursue the appropriate legal course and evaluate constructive alternatives where possible, our priority remains clear: stabilizing the business, preserving the value of our core operations, and positioning the Company for a more resilient and sustainable future."


Key Financial Metrics Table 1: 3Q26 Key Financial Metrics

(In millions of U.S. dollars)	3Q25	3Q26	%CHANGE
Revenue by Segment
Crop Protection	30.1	24.6	-18%
Seed and Integrated Products	10.9	3.2	-71%
Crop Nutrition	10.1	11.6	15%
Total Revenue	51.1	39.4	-23%
Gross Profit	18.1	12.7	-30%
Gross Margin	35%	32%	-310 bpts

	3Q25	3Q26	%CHANGE
GAAP Net income or loss	2.3	(10.0)	-528%
Adjusted EBITDA¹	9.1	(0.6)	-107%

3Q26 Summary: Revenue performance in the third quarter reflects mixed demand dynamics across segments, particularly in Crop Protection, together with the ongoing transition in Seeds toward a more asset-light model. While these factors weighed on reported revenues, Crop Nutrition continued to grow, driven by microbeaded fertilizers.

Gross profit and margins declined year over year, reflecting lower revenues, product mix effects, and the impact of a non-recurring obsolescence adjustment in inoculants, associated with inventory normalization efforts during the period.

At the same time, the Company continued to execute on cost management and working capital initiatives, resulting in meaningful reductions in operating expenses and improvements in cash conversion dynamics during the quarter.

Profitability metrics were additionally impacted by the absence of prior year non-cash income associated with changes in contractual obligations and intellectual property arrangements as part of the reorganization in Seeds, which affected year-over-year comparability.

For a full version of Bioceres' third quarter 2026 earnings release, click here

Fiscal Third Quarter 2026 Earnings Conference Call

Management will host a conference call and question-and-answer session, which will be accompanied by a presentation available during the webcast or accessed via the investor relations section of the company's website.

To access the call, please use the following information:

	Date: Wednesday, May 12, 2026
	Time: 8:30 a.m. EST, 5:30 a.m. PST		Please dial in 5-10 minutes prior to the start time to register and join. The conference call will be broadcast live and available for replay here and via the investor relations section of the company's website here.
	US Toll Free dial-in number: 1-833-461-5787
	International dial-in numbers: Click here
	Conference ID: 717574163
	Webcast: Click here

About Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. The company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation Crop Nutrition and Protection solutions. For more information, visit here.

Forward-Looking Statements

This communication includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "expect," "estimate," "plan," "outlook," and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include estimated financial data, and any such forward-looking statements involve risks, assumptions and uncertainties. These forward-looking statements include, but are not limited to, whether (i) the health and safety measures implemented to safeguard employees and assure business continuity will be successful and (ii) we will be able to coordinate efforts to ramp up inventories. Such forward-looking statements are based on management's reasonable current assumptions, expectations, plans and forecasts regarding the company's current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management's expectations or could affect the company's ability to achieve its strategic goals, including the uncertainties relating to the other factors that are described in the sections entitled "Risk Factors" in the company's Securities and Exchange Commission filings updated from time to time. The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. All forward-looking statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and the company does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.



Unaudited Consolidated Statement of Comprehensive Income (Figures in million of U.S. dollars)


*Continuing operations*	Three-month period ended 03/31/2026	Three-month period ended 03/31/2025
Revenues from contracts with customers	38.2	50.1
Initial recognition and changes in the fair value of biological assets at the point of harvest	1.2	1.0
Cost of sales	(26.7)	(33.0)
Gross profit	12.7	18.1
% Gross profit	32%	35%
Operating expenses	(18.0)	(21.3)
Share of profit of JV	0.5	(0.9)
Change in net realizable value of agricultural products	(0.2)	(0.2)
Other income or expenses, net	0.7	8.8
Operating profit	(4.3)	4.3
Financial result	(9.7)	(5.6)
Profit/(loss) before income tax	(14.1)	(1.2)
Income tax	4.0	3.6
Profit/(loss) for the period from continuing operations	(10.0)	2.3

*Discontinued operations*
Loss for the period from discontinued operations	-	(3.9)
Loss for the period from discontinued operations	-	(3.9)

Other comprehensive profit/loss	0.3	(0.8)
Total comprehensive profit/(loss)	(9.7)	(2.4)

Profit/(loss) for the period of continuing operations attributable to
Equity holders of the parent	(9.0)	2.6
Non-controlling interests	(1.1)	(0.3)
	(10.0)	2.3

Weighted average number of shares
Basic	63.6	62.8
Diluted	63.6	62.8





Unaudited Consolidated Statement of Financial Position (Figures in million of U.S. dollars)

ASSETS	31/03/2026	30/06/2025
CURRENT ASSETS
Cash and cash equivalents	14.4	32.7
Other financial assets	0.5	2.0
Trade receivables	136.3	165.9
Other receivables	13.0	15.9
Recoverable income tax	1.4	1.9
Inventories	48.4	87.6
Biological assets	4.4	2.4
Assets subject to foreclosure	42.4	-
Total current assets	260.7	308.3
NON-CURRENT ASSETS
Other financial assets	0.0	0.0
Trade receivables	4.8	2.5
Other receivables	25.7	23.7
Recoverable income tax	0.0	0.0
Deferred tax assets	6.5	4.9
Investments in joint ventures and associates	40.6	39.4
Investment properties	-	0.6
Property, plant and equipment	60.0	74.6
Intangible assets	83.9	181.2
Goodwill	36.1	112.2
Right of use asset	11.4	16.4
Total non-current assets	268.9	455.3
Total assets	529.6	763.6

LIABILITIES	31/03/2026	30/06/2025
CURRENT LIABILITIES
Trade and other payables	79.6	96.4
Borrowings	66.4	119.7
Employee benefits and social security	3.6	6.2
Deferred revenue and advances from customers	2.8	4.3
Income tax payable	4.8	0.5
Consideration for acquisition	2.1	1.8
Secured notes	108.3	102.3
Lease liabilities	2.6	6.9
Liabilities subject to foreclosure	27.4	-
Total current liabilities	297.5	338.0
NON-CURRENT LIABILITIES
Trade and other payables	46.2	48.5
Borrowings	54.1	38.2
Deferred revenue and advances from customers	1.4	1.4
Joint ventures and associates	0.7	1.0
Deferred tax liabilities	24.3	30.1
Provisions	1.0	1.3
Consideration for acquisition	0.0	0.4
Secured notes	-	-
Lease liabilities	8.6	9.5
Total non-current liabilities	136.4	130.4
Total liabilities	433.9	468.4
EQUITY
Equity attributable to owners of the parent	67.7	265.4
Non-controlling interest	27.9	29.8
Total equity	95.7	295.2
Total equity and liabilities	529.6	763.6

View source version on businesswire.com: https://www.businesswire.com/news/home/20260511356435/en/

Bioceres Crop Solutions

Paula Savanti

Head of Investor Relations

investorrelations@biocerescrops.com

Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results